Rosen Law Firm's Ongoing Investigation into Disc Medicine, Inc. Securities Claims

The Rosen Law Firm, a notable law firm specializing in investor rights, is actively probing potential security claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON). This investigation emerges from allegations suggesting that Disc Medicine may have disseminated materially misleading business information to the public, potentially affecting the value of their securities. If you are among the investors who purchased shares in Disc Medicine, you might be eligible for compensation through a class action lawsuit without incurring out-of-pocket expenses, thanks to the law firm’s contingency fee arrangement.

The Catalyst for the Investigation

On February 13, 2026, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Disc Medicine's application for its bitopertin program. The FDA’s letter stated that it could not approve the company’s new drug application (NDA) due to certain unresolved technical concerns that required more substantial evidence. Upon this announcement, Disc Medicine's stock plummeted by 22%, triggering alarm among investors and intensifying the scrutiny on the company's operational transparency.

Next Steps for Investors

For those affected investors who wish to join the prospective class action, you can do so by visiting the Rosen Law Firm's website or by directly reaching out to Phillip Kim, Esq. For inquiries, you can call their toll-free number at 866-767-3653 or email [email protected]. The Rosen Law Firm is committed to ensuring that shareholder rights are upheld and aims to recover investor losses effectively.

Why Trust Rosen Law Firm

Investors are strongly encouraged to seek seasoned counsel with a proven history of success. The Rosen Law Firm has an outstanding reputation in handling securities class actions, boasting a track record of significant settlements. Notably, they have successfully achieved the largest securities class action settlement against a Chinese company and have ranked among the top firms for securities class action settlements since 2013.

In 2019 alone, they recovered over $438 million for investors, demonstrating their capability and commitment to their clients. Founding partner Laurence Rosen was recognized as a Titan of the Plaintiffs’ Bar by Law360 in 2020, showcasing the firm’s prominence in the legal industry. Numerous attorneys within the firm have also received accolades from Lawdragon and Super Lawyers, further establishing their expertise.

Investors are reminded to select legal counsel wisely, as many firms that advertise do not possess comparable experience or genuine recognition in securities litigation.

Stay Updated

To keep abreast of developments regarding this investigation and others, follow the Rosen Law Firm on various social media platforms, including LinkedIn, Twitter, and Facebook.

In conclusion, if you invested in Disc Medicine, it’s crucial to evaluate your options moving forward with a capable law firm that can help navigate the complexities of securities litigation. Rosen Law Firm is ready to assist and advocate for your rights as an investor, ensuring that you are not left vulnerable following possible misleading information provided by Disc Medicine.